The Rising Demand and Future Trends in the Bioprocess Bags Market

MARKET OVERVIEW:

The global bioprocess bags market, valued at USD 4.0 billion in 2024, is projected to grow at a CAGR of 14.62%, reaching USD 14.4 billion by 2033. Key drivers include the increasing demand for biopharmaceuticals, advancements in single-use technologies, and the rapid growth of personalized medicine. The market benefits from rising investments in biomanufacturing infrastructure, the adoption of cell and gene therapies, and the widespread use of flexible, cost-effective bioprocessing solutions in pharmaceutical manufacturing.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019-2024
• FORECAST YEAR: 2025-2033

BIOPROCESS BAGS MARKET KEY TAKEAWAYS:

• The market size was USD 4.0 billion in 2024 and is forecasted to reach USD 14.4 billion by 2033, growing at a CAGR of 14.62%.
• Advancements in single-use technologies and growing demand for biopharmaceuticals are key growth drivers.
• North America leads the market, driven by strong biopharmaceutical infrastructure and R&D investment.
• Increasing demand for personalized medicines is significantly influencing market expansion.
• Cell and gene therapies are a major trend in bioprocessing, boosting market demand.
• Growing environmental concerns are prompting the development of biodegradable bioprocess bags.

MARKET GROWTH FACTORS:

Rising Demand for Biopharmaceuticals:

Bioprocess bags are the emerging trend necessities due to the rising need for biopharmaceuticals, which include vaccines, monoclonal antibodies, and cell therapies. They are the most economical and flexible means of providing a sterile environment to manufacture biopharmaceuticals, according to experts in the industry. Biomanufacturing creates a site-specific infrastructure, making bioprocess bags even more suited for the efficient handling, storage, and processing of biologics, contributing toward enhancing further adoption across the pharmaceutical sector worldwide.

Advancements in Single-Use Technologies (SUT):

Single-use technologies are the primary revolution in the biomanufacturing sector, with bioprocess bags among its features. They minimize the cost associated with cleaning and sterilizing conventional systems, allowing greater manufacturing flexibility. The functional efficiency of bioprocess bags has been raised higher by developments in barrier properties improvement and multi-layer films. These spur expansion in market sales, particularly in countries with a strong biopharma market such as North America and Europe.

Expansion of Personalized Medicine:

The last few years have seen the rise of personalized medicine across most areas of healthcare, with its predominant interest being tailoring treatments to specific genetic profiles. Bioprocess bags enable and support the efficient and scalable production processes needed to produce biologics for personalized therapies. The most flexible bioprocess bags are such that they can very easily be adapted to smaller, more varied production needs, making them ideal for driving market demand for personalized medicine.

MARKET SEGMENTATION:

• By Type:
  • 2D Bioprocess Bags: Commonly used in the biopharmaceutical sector for processes like mixing, storage, and transportation.
  • 3D Bioprocess Bags: Primarily used for cell culturing and fermentation in biomanufacturing processes.
  • Other Bags and Accessories: Includes specialized bags and accessories designed for specific bioprocessing needs.
• By Workflow:
  • Upstream Process: Involves the preparation and development of cells for biopharmaceutical production.
  • Downstream Process: Includes the steps of recovery, purification, and processing of final bioproducts.
  • Process Development: Involves the scaling and optimization of biomanufacturing techniques.
  • Others: Includes other workflows essential for biomanufacturing processes.
• By End User:
  • Pharmaceutical and Biopharmaceutical Companies: The largest segment, using bioprocess bags for production, storage, and transportation.
  • CMOs and CROs: Contract manufacturing organizations and contract research organizations that support biopharma production and research.
  • Academic and Research Institutes: Use bioprocess bags for research and development activities.
  • Others: Includes various other industries and sectors that require bioprocessing solutions.
• Breakup by Region:
  • North America: Largest market share, driven by robust pharmaceutical infrastructure.
  • Europe: Advanced biopharma markets with increasing demand for personalized medicine.
  • Asia-Pacific: Rapidly expanding market due to growing biopharma investments.
  • Latin America: Emerging market with increasing biomanufacturing activity.
  • Middle East and Africa: Gradual growth in biopharmaceutical production and adoption of bioprocess bags.

REGIONAL INSIGHTS:

The North America market leads the global bioprocess bags market due to the well-established biopharmaceutical industry coupled with significant investments in the biomanufacturing construction infrastructure. North America is at the forefront of technology development around cell therapies, personalized medicine, and single-use technologies. Furthermore, continuing strong spending in research and development will constantly stimulate growth in the bioprocess bags market.

RECENT DEVELOPMENTS & NEWS:

Current developments in bioprocess bags refer to the development of single-use technologies, in which the technology shows advantages in terms of variable costs and flexibility in biomanufacturing. Demand for personalized medicines and cell therapies has propelled the use of bioprocess bags, which are regarded as a mature technology for the manufacture of such highly engineered therapies. Current trends show a preference for biodegradable and more sustainable bioprocessing solutions.

KEY PLAYERS:

CellBios Healthcare & Lifesciences Pvt. Ltd., Charter Medical Ltd. (Solesis Medical Technologies Inc.), Compagnie de Saint-Gobain S.A., Danaher Corporation, Entegris Inc, FlexBiosys Inc. (Repligen Corporation), ILC Dover LP, Indutrade AB, PROAnalytics LLC, Sartorius AG, Thermo Fisher Scientific Inc., etc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, considerations studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.